← FDA Drug Approvals (Drugs@FDA)
FOSAPREPITANT DIMEGLUMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2021-07-29
Drug application
- FDA Application #
ANDA214616- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FOSAPREPITANT DIMEGLUMINE
- Generic name
- FOSAPREPITANT DIMEGLUMINE
- Active ingredients
- FOSAPREPITANT DIMEGLUMINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ASPIRO
- Manufacturer
- NorthStar RxLLC
- First approval
- 2021-07-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown